Equities
Health CareHealth Care Equipment & Services
  • Price (USD)66.25
  • Today's Change-0.65 / -0.97%
  • Shares traded5.28m
  • 1 Year change17.82%
  • Beta0.7110
Data delayed at least 15 minutes, as of May 29 2020 21:00 BST.
More ▼

Profile data is unavailable for this security.

About the company

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company's Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace. Its Specialty Services segment consists of its specialty companies offering a range of healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to its own subsidiaries.

  • Revenue in USD (TTM)82.22bn
  • Net income in USD845.00m
  • Incorporated2001
  • Employees56.60k
  • Location
    Centene Corp7700 Forsyth BlvdST. LOUIS 63105-1807United StatesUSA
  • Phone+1 (314) 725-4477
  • Fax+1 (302) 655-5049
  • Websitehttps://www.centene.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Universal Health Services, Inc.11.40bn720.84m8.95bn67.70k12.871.657.280.78528.198.19129.7263.740.9771--7.38168,442.206.297.387.408.67----6.447.510.98926.380.40945.615.636.765.208.3210.1314.87
Davita Inc11.49bn816.13m9.86bn65.00k13.905.065.960.85855.826.3579.8615.990.571479.286.09176,717.005.154.477.675.8031.0129.499.017.131.774.890.71870.00-0.1436-2.3014.45-0.4923.63--
Molina Healthcare, Inc.17.26bn717.00m11.00bn10.00k16.256.6613.730.637411.4311.43275.2627.922.35--11.651,725,900.009.753.3520.958.2317.4315.244.151.35--12.290.52920.00-10.9111.734.2463.76-13.09--
Quest Diagnostics Inc7.66bn771.00m15.82bn47.00k20.892.8014.542.075.665.8156.3042.220.638544.927.47162,914.906.326.907.467.9734.3036.969.909.701.277.340.411234.052.590.770816.138.755.3710.45
Laboratory Corp. of America Holdings11.59bn321.00m17.04bn65.00k53.962.4218.801.473.253.25118.2272.300.676334.435.87178,267.701.884.902.205.6227.5429.712.787.041.076.540.47250.001.9513.96-11.2910.0114.48--
HCA Healthcare Inc51.68bn3.05bn36.09bn210.00k12.17--5.720.69848.798.79149.07-8.771.164.597.22246,095.208.259.5110.9512.2883.4383.357.097.701.293.901.027.369.986.828.3113.3313.83--
Centene Corp82.22bn845.00m38.37bn56.60k33.401.6323.800.46661.981.98181.2840.661.64--9.601,452,650.001.673.672.576.1717.1217.971.021.54--4.850.42170.0024.1635.1446.7837.5847.94--
Humana Inc67.72bn2.61bn54.29bn46.00k21.094.3917.080.801719.4819.48505.5793.452.15----1,472,087.008.246.88--------3.833.12--14.250.396712.9214.015.9957.2018.746.8714.34
Data as of May 29 2020. Currency figures normalised to Centene Corp's reporting currency: US Dollar USD

Institutional shareholders

49.36%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202062.92m10.87%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 202050.93m8.79%
Capital Research & Management Co. (World Investors)as of 31 Mar 202039.18m6.77%
BlackRock Fund Advisorsas of 31 Mar 202030.14m5.20%
Fidelity Management & Research Co. LLCas of 31 Mar 202026.61m4.59%
SSgA Funds Management, Inc.as of 31 Mar 202024.46m4.22%
Wellington Management Co. LLPas of 31 Mar 202018.93m3.27%
Viking Global Investors LPas of 31 Mar 202016.23m2.80%
Geode Capital Management LLCas of 31 Mar 20209.19m1.59%
Farallon Capital Management LLCas of 31 Mar 20207.25m1.25%
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.